Negative regulation of platelet-derived growth factor receptor signaling pathway

pathway activity — cross-omics
GO:0010642Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of platelet-derived growth factor receptor signaling pathway pathway is significantly associated with the RNA expression of multiple genes, with the PDAC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ESRP2, NEK8, and BCL2A1, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of platelet-derived growth factor receptor signaling pathway activity versus ESRP2 in PDAC (Pearson r = -0.34).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
PDACESRP2 →-0.302-0.188.003.00635
PDACNEK8 →-0.235-0.283.001.00435
UCECBCL2A1 →+1.269+0.424<.001.00835
BRCATUBB6 →+0.946+0.206.001.00135
BRCAC9orf152 →-1.643-0.160.001.00835
GBMLGALS1 →+0.744+0.181.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0010642 vs ESRP2 — PDAC

Per-sample scatter of Negative regulation of platelet-derived growth factor receptor signaling pathway activity vs ESRP2 in PDAC.

Explore this scatter interactively →

Exploration